Novanta (NOVT) Return on Sales (2016 - 2025)
Historic Return on Sales for Novanta (NOVT) over the last 17 years, with Q3 2025 value amounting to 0.04%.
- Novanta's Return on Sales fell 400.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.05% for FY2024, which is 200.0% down from last year.
- As of Q3 2025, Novanta's Return on Sales stood at 0.04%, which was down 400.0% from 0.02% recorded in Q2 2025.
- Over the past 5 years, Novanta's Return on Sales peaked at 0.1% during Q3 2022, and registered a low of 0.02% during Q4 2022.
- Its 5-year average for Return on Sales is 0.06%, with a median of 0.07% in 2021.
- In the last 5 years, Novanta's Return on Sales tumbled by -600bps in 2022 and then skyrocketed by 300bps in 2025.
- Quarter analysis of 5 years shows Novanta's Return on Sales stood at 0.05% in 2021, then plummeted by -132bps to 0.02% in 2022, then skyrocketed by 33bps to 0.01% in 2023, then soared by 122bps to 0.0% in 2024, then skyrocketed by 1744bps to 0.04% in 2025.
- Its last three reported values are 0.04% in Q3 2025, 0.02% for Q2 2025, and 0.09% during Q1 2025.